Last Week in Medicine

Balanced Crystalloid vs Normal Saline (PLUS trial), Midline vs PICC, LOLA for Hepatic Encephalopathy, Eat-Walk-Engage Program for Older Inpatients, Post-Discharge Thromboprophylaxis for COVID-19, Mindfulness Training and Burnout

January 27, 2022 Stephen Jenkins, MD, Brian Locke, MD Season 3 Episode 5
Last Week in Medicine
Balanced Crystalloid vs Normal Saline (PLUS trial), Midline vs PICC, LOLA for Hepatic Encephalopathy, Eat-Walk-Engage Program for Older Inpatients, Post-Discharge Thromboprophylaxis for COVID-19, Mindfulness Training and Burnout
Show Notes

Today we are joined by Dr. Brian Locke to talk about the newest big trial on IV fluids in critically ill patients and a meta-analysis that looks at all the similar trials. Is this question finally settled?

We also look at PICC lines vs midlines, IV L-ornithine L-aspartate in acute treatment of hepatic encephalopathy, a new ward-based program for delirium prevention in older inpatients, post-discharge thromboprophylaxis for high risk COVID patients, and whether mindfulness training can help burnout in residents.

Balanced Multielectrolyte Solution vs Normal Saline in Critically Ill Patients (PLUS)
Balanced Crystalloid vs Normal Saline Meta-analysis
PICC lines vs Midlines
Apixaban vs Rivaroxaban for Recurrent VTE
LOLA for Hepatic Encephalopathy
Eat-Walk-Engage in Older Inpatients (CHERISH)
Rivaroxaban for Post-discharge Prophylaxis in High Risk COVID patients (MICHELLE)
Mindfulness Training and Burnout








Music from Uppbeat (free for Creators!):

https://uppbeat.io/t/soundroll/dope

License code: NP8HLP5WKGKXFW2R